Dr. Dweep Kamlesh Barbhaya, MD

Dr. Barbhaya practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Barbhaya's NPI, 1386205441, was assigned on June 27, 2019. Dr. Barbhaya holds District of Columbia license MD210001809.

Dr. Barbhaya's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Barbhaya's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Barbhaya to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barbhaya practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Barbhaya's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Barbhaya is licensed in District of Columbia.

CMS data shows 792 Medicare services from Dr. Barbhaya across 6 procedure codes in 2024, for 264 Medicare patients. Medicare paid $71,871 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 264 Medicare patients who saw Dr. Barbhaya in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barbhaya's median patient age at 64, with 51% women.

In 2024, Dr. Barbhaya wrote 659 Medicare Part D claims for 117 patients. 84% of them were for generic drugs. CMS names the drug for 352 of them, across 16 drugs with 11 or more claims each, at $50,583 in total drug cost. In 2023, CMS named 243 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Barbhaya for performance year 2024, reported as part of a group. Dr. Barbhaya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Barbhaya, published from 2017 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Diabetes Mellitus, Hypertension and India. Dr. Barbhaya's most frequent co-authors are Richard A. Josephson, MD, Manyoo Agarwal, MD and Dawn A. Fishbein, MD.

CMS Open Payments shows 8 general payments to Dr. Barbhaya from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $149.